Atherosclerosis is responsible for large cardiovascular mortality in many countries globally. It
has been shown over the last decades that the reduction of atherosclerotic progression is a …

Prevention of Cardiovascular Disease in Type 1 Diabetes | New England Journal of Medicine
Skip to main content The New England Journal of Medicine homepage Advanced Search …

The prevalence of diabetes is growing at an alarming rate with increased disability,
morbidity, and often premature mortality because of the various complications of this …

Type 1 diabetes (T1D) patients show lipid disorders which are likely to play a role in their
increased cardiovascular (CV) disease risk. Quantitative abnormalities of lipoproteins are …

A direct and an indirect relationship between paraoxonase 1 (PON1) and atherosclerosis
exists. Given PON1's physical location within high‐density lipoprotein (HDL) particles and its …

Background Lipoprotein disturbances have been associated with increased cardiovascular
disease (CVD) risk in type 1 diabetes mellitus (T1DM). We assessed the advanced …

Background Previous studies reported that proprotein convertase subtilisin/kexin type 9
(PCSK9) was a key player in the regulations of lipid metabolism and glucose homeostasis …

Hashimoto autoimmune thyroiditis (AIT) is the most common cause of acquired
hypothyroidism in the pediatric population. Development of AIT is mediated mainly by …

Background Proprotein convertase subtilisin/kexin type 9 (PCSK9) regulates cholesterol
metabolism by targeting the low-density lipoprotein receptor. Recent studies have shown …

Lipid management for cardiovascular risk reduction in type 1... : Current Opinion in
Endocrinology, Diabetes and Obesity Lipid management for cardiovascular risk reduction in type …